TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07606664: Fezolinetant and Vascular Health and Brain Health

Sponsor: Rebecca Thurston · Phase: PHASE3 · Area: CNS_NEUROLOGY · Target Enrollment: 220 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$17,630,720

Rescue Site Savings

+$11,625,256

Unlock Full NCT07606664 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07606664 Rescue Dossier →